Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis

BACKGROUND AND OBJECTIVES: Evidence suggests that sustained virologic response to interferon treatment decreases incidence of hepatocellular carcinoma in patients with hepatitis C virus cirrhosis. This study was designed to compare the incidence of hepatocellular carcinoma among cirrhotic patients e...

Full description

Bibliographic Details
Main Authors: Nelson Cheinquer, Hugo Cheinquer, Fernando H Wolff, Silvia Coelho-Borges
Format: Article
Language:English
Published: Elsevier
Series:Brazilian Journal of Infectious Diseases
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702010000500006&lng=en&tlng=en
_version_ 1819025467129200640
author Nelson Cheinquer
Hugo Cheinquer
Fernando H Wolff
Silvia Coelho-Borges
author_facet Nelson Cheinquer
Hugo Cheinquer
Fernando H Wolff
Silvia Coelho-Borges
author_sort Nelson Cheinquer
collection DOAJ
description BACKGROUND AND OBJECTIVES: Evidence suggests that sustained virologic response to interferon treatment decreases incidence of hepatocellular carcinoma in patients with hepatitis C virus cirrhosis. This study was designed to compare the incidence of hepatocellular carcinoma among cirrhotic patients exposed to interferon based treatment with or without achieving a sustained virological response, in order to evaluate the role of interferon itself in the prevention hepatocellular carcinoma. METHODS: A cohort of 85 patients with compensated hepatitis C cirrhosis was followed after treatment with interferon and ribavirin. Sustained virological response was defined as negative polymerase chain reaction assay 24 weeks after the end of treatment. Patients were followed every 6 months with ultrasound and alpha-fetoprotein. Hepatocellular carcinoma was diagnosed by the finding of a focal liver lesion greater than 2 cm with arterial hypervascularization on two imaging techniques and/or by liver biopsy. RESULTS: The mean follow-up time was 32.1 ± 20 months for patients who achieved a sustained virological response and 28.2 ± 18 months among 47 patients (55%) without SVR. Hepatocellular carcinoma was diagnosed in 1 (3%) vs. 8 (17%) responders and non responders respectively (p = 0.02). CONCLUSION: Patients with cirrhosis due to hepatitis C virus who achieved sustained virological response had significantly lower incidence of hepatocellular carcinoma when compared to those without treatment response. Interferon treatment without achieving sustained virological response does not seem to protect against hepatocellular carcinoma
first_indexed 2024-12-21T05:11:08Z
format Article
id doaj.art-8ac62f52411548669758ad2879156eec
institution Directory Open Access Journal
issn 1678-4391
language English
last_indexed 2024-12-21T05:11:08Z
publisher Elsevier
record_format Article
series Brazilian Journal of Infectious Diseases
spelling doaj.art-8ac62f52411548669758ad2879156eec2022-12-21T19:15:04ZengElsevierBrazilian Journal of Infectious Diseases1678-439114545746110.1590/S1413-86702010000500006S1413-86702010000500006Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosisNelson CheinquerHugo CheinquerFernando H WolffSilvia Coelho-BorgesBACKGROUND AND OBJECTIVES: Evidence suggests that sustained virologic response to interferon treatment decreases incidence of hepatocellular carcinoma in patients with hepatitis C virus cirrhosis. This study was designed to compare the incidence of hepatocellular carcinoma among cirrhotic patients exposed to interferon based treatment with or without achieving a sustained virological response, in order to evaluate the role of interferon itself in the prevention hepatocellular carcinoma. METHODS: A cohort of 85 patients with compensated hepatitis C cirrhosis was followed after treatment with interferon and ribavirin. Sustained virological response was defined as negative polymerase chain reaction assay 24 weeks after the end of treatment. Patients were followed every 6 months with ultrasound and alpha-fetoprotein. Hepatocellular carcinoma was diagnosed by the finding of a focal liver lesion greater than 2 cm with arterial hypervascularization on two imaging techniques and/or by liver biopsy. RESULTS: The mean follow-up time was 32.1 ± 20 months for patients who achieved a sustained virological response and 28.2 ± 18 months among 47 patients (55%) without SVR. Hepatocellular carcinoma was diagnosed in 1 (3%) vs. 8 (17%) responders and non responders respectively (p = 0.02). CONCLUSION: Patients with cirrhosis due to hepatitis C virus who achieved sustained virological response had significantly lower incidence of hepatocellular carcinoma when compared to those without treatment response. Interferon treatment without achieving sustained virological response does not seem to protect against hepatocellular carcinomahttp://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702010000500006&lng=en&tlng=enhepatocellular carcinomaHCV interferonsustained virologic responsecirrhosis
spellingShingle Nelson Cheinquer
Hugo Cheinquer
Fernando H Wolff
Silvia Coelho-Borges
Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis
Brazilian Journal of Infectious Diseases
hepatocellular carcinoma
HCV interferon
sustained virologic response
cirrhosis
title Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis
title_full Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis
title_fullStr Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis
title_full_unstemmed Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis
title_short Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis
title_sort effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with hcv cirrhosis
topic hepatocellular carcinoma
HCV interferon
sustained virologic response
cirrhosis
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702010000500006&lng=en&tlng=en
work_keys_str_mv AT nelsoncheinquer effectofsustainedvirologicresponseontheincidenceofhepatocellularcarcinomainpatientswithhcvcirrhosis
AT hugocheinquer effectofsustainedvirologicresponseontheincidenceofhepatocellularcarcinomainpatientswithhcvcirrhosis
AT fernandohwolff effectofsustainedvirologicresponseontheincidenceofhepatocellularcarcinomainpatientswithhcvcirrhosis
AT silviacoelhoborges effectofsustainedvirologicresponseontheincidenceofhepatocellularcarcinomainpatientswithhcvcirrhosis